The global remote patient monitoring system market size was estimated at USD 22.03 billion in 2024 and is projected to reach USD 110.71 billion by 2033, growing at a CAGR of 19.8% from 2025 to 2033. The increasing demand for RPM systems is largely driven by their ability to enhance chronic disease management by providing early warning signs, continuous monitoring, and progress tracking, which collectively improve patient outcomes and reduce healthcare burdens.

The COVID-19 pandemic played a significant role in accelerating the adoption of remote patient monitoring systems. During the pandemic, hospitals experienced space shortages, and patients—particularly those with chronic conditions—were advised to avoid in-person visits due to the risk of infection. This situation created an urgent need for remote monitoring solutions, driving growth in the RPM market as healthcare providers sought alternatives to ensure continuous patient care.

Healthcare firms have responded by making substantial investments, forming collaborations, acquisitions, and partnerships with emerging startups to expand RPM capabilities. The development of personalized telemedicine applications has created a secure communication platform that enables remote and real-time monitoring of patients, acting as a bridge between caregivers and patients. This innovation, initially accelerated by necessity during the pandemic, has reshaped the remote patient monitoring market. It has led to faster recovery rates, increased patient willingness to use RPM apps, greater provider adoption, and expanded access to care and reimbursement opportunities. These factors are expected to continue driving the demand for remote patient monitoring systems globally over the coming years.

Key Market Trends & Insights:

• North America dominated the global remote patient monitoring (RPM) system market, accounting for a 40.5% share in 2024, driven by advanced healthcare infrastructure, high adoption of digital health technologies, and the presence of key market players in the region.

• Within North America, the U.S. RPM market has experienced significant growth over the forecast period, largely due to the increasing adoption of integrated remote monitoring solutions that combine devices, software platforms, and telehealth services to enhance patient care and chronic disease management.

• Based on product type, the special monitors segment led the market, holding a dominant share of 89.95% in 2023. This reflects the critical role of specialized monitoring devices in tracking vital signs, glucose levels, cardiac activity, and other health parameters, which are essential for effective remote patient care.

• By application, diabetes management emerged as the leading segment in 2024, accounting for 13.1% of the market share. The high prevalence of diabetes globally, coupled with the need for continuous glucose monitoring and timely interventions, has made RPM systems particularly vital for diabetes patients.

• Based on end-use, the hospital-based patient segment led the market in 2024, representing 61.46% of the market share. Hospitals utilize RPM systems extensively to monitor patients’ vital parameters in real time, reduce hospital readmissions, manage chronic diseases efficiently, and improve overall patient outcomes.

Order a free sample PDF of the Remote Patient Monitoring System Market Intelligence Study, published by Grand View Research.

Market Size & Forecast:

• 2024 Market Size: USD 22.03 Billion

• 2033 Projected Market Size: USD 110.71 Billion

• CAGR (2025-2033): 19.8%

• North America: Largest market in 2024

• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights:

The remote patient monitoring (RPM) system market is highly fragmented, comprising a diverse mix of both small-scale and large-scale players. This diversity creates an environment of intense competition, particularly among smaller companies that are striving to maintain and strengthen their market positions. To stay competitive, companies are increasingly adopting strategic initiatives such as launching new and innovative products, forming partnerships and collaborations, and expanding their service offerings. These strategies are critical in driving market growth, as they allow players to enhance technological capabilities, improve patient care solutions, expand geographic reach, and differentiate themselves in a rapidly evolving healthcare ecosystem.

Key Players

• Shenzhen Mindray Bio-Medical Electronics Co., Ltd

• Nihon Kohden Corporation

• Omron Corporation

• OSI Systems, Inc.

• Koninklijke Philips N.V.

• F. Hoffmann-La Roche Ltd

• Welch Allyn

• Smiths Medical

• Abbott

• Boston Scientific Corporation

• Dräger Medical

• GE Healthcare

• Honeywell

• Johnson & Johnson

• LifeWatch

• Medtronic

• Masimo

• Vitls, Inc

• CareValidate

• Biotronik

• American Telecare

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion:

The RPM market is set for substantial growth, driven by the rising prevalence of chronic diseases and the growing elderly population that requires continuous health monitoring. The COVID 19 pandemic significantly accelerated adoption, as remote monitoring offered a safe, effective alternative when hospital visits were limited. Integration of telehealth, smart devices, and AI enabled monitoring systems has increased demand for RPM globally. Hospitals remain the dominant end user, while specialized monitoring devices lead the product segment. As awareness grows and technology advances further, RPM is becoming an essential pillar in modern, patient centric healthcare delivery.